Partnership will pursue cellular therapies for hard-to-treat wounds

04/9/2012 | Pharmaceutical Business Review Online

The human-based protein Elastatropin and technology involving adipose-derived stem cells and stromal cell culture media will be used to develop cellular treatments for wound healing and regenerative therapies. American CryoStem and Protein Genomics have formed a partnership that will focus on therapies for difficult-to-treat conditions.

View Full Article in:

Pharmaceutical Business Review Online

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Vice President, Idaho Regional Director
PacificSource
Boise, ID